BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Fluoxetine
,
rs4950928
,
CXCL2
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
integrin- linked kinase
Summary
General Info
Curated Studies
Most Correlated Studies
Human umbilical vein endothelial cells (HUVECs) adhering to soluble VEGFR1 or fibronectin
Melanoma M21 cells with high or low integrin-α5 expression in two or three dimensional culture
Cardiac neural crest cells from outflow tract of E10.5 embryos with ILK knockout
Mesenchymal stromal cells treated with EGF and WNT pathway inhibitor IWR-1
Femoral diaphysis of male Sprague-Dawley rats after 15d of bipedal stance or wheel exercise
Explore Curated Studies Results
Literature
Most Relevant Literature
Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle.
Overexpression of ILK promotes temozolomide resistance in glioma cells.
Integrin linked kinase regulates the transcription of AQP2 by NFATC3.
Peripheral insulin resistance in ILK-depleted mice by reduction of GLUT4 expression.
ILK and cytoskeletal architecture: an important determinant of AQP2 recycling and subsequent entry i…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or A…
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion…
SF1126 for Patients With Relapsed or Refractory Neuroblastoma
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ